Filter your results
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular diseaseNature Reviews Cardiology, 2020, 17 (4), pp.242-257. ⟨10.1038/s41569-019-0314-y⟩
Journal articles
hal-02964558v1
|
||
|
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent ImplantationJAMA Cardiology, 2021, 6 (4), pp.410. ⟨10.1001/jamacardio.2020.6814⟩
Journal articles
hal-03257261v1
|
||
|
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research ConsortiumCirculation, 2023, 145 (11), pp.847-863. ⟨10.1161/CIRCULATIONAHA.121.057687⟩
Journal articles
hal-04051030v1
|